Organization Profile

Related Organization(s)

You just read:

Baricitinib Demonstrates Early Response Compared to Placebo and Significant Improvement Compared to Adalimumab in Patient-Reported Outcomes

News provided by

Eli Lilly and Company

Nov 14, 2016, 09:00 ET